-
Product Insights
Influenzavirus B Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Influenzavirus B Infections - Drugs In Development, 2023’, provides an overview of the Influenzavirus B Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Influenzavirus B Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Product Insights
Influenzavirus A Infections – Drugs In Development, 2023
Global Markets Direct’s, ‘Influenzavirus A Infections - Drugs In Development, 2023’, provides an overview of the Influenzavirus A Infections pipeline landscape. The report provides comprehensive information on the therapeutics under development for Influenzavirus A Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...
-
Sector Analysis
Sportswear Market Size, Share and Trend Analysis by Segments, Region, Category Performance and Competitive Landscape to 2027
Sportswear Market Overview The sportswear market size was valued at $441 billion in 2022. The market is expected to achieve a CAGR of more than 5% from 2022 to 2027. The sportswear market growth is attributed to the consumer apparel preferences remaining geared towards sportswear styles. Consumers are continuing to prioritize their health and fitness and try out new sports. Furthermore, the sportswear market will outperform the total apparel market as the versatility and comfort of athleisure items remain highly...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Pemigatinib in Endometrial Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Pemigatinib in Endometrial Cancer Drug Details: Pemigatinib (Pemazyre) is acts as an anti neoplastic agent....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – DF-9001 in Hypopharyngeal Cancer
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. DF-9001 in Hypopharyngeal Cancer Drug Details: DF-9001 is under development for the treatment of solid...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – INCA-033989 in Essential Thrombocythemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - INCA-033989 in Essential Thrombocythemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. INCA-033989 in Essential Thrombocythemia Drug Details: INCA-033989 is under development for the...
-
Product Insights
Swire Pptys – Taikoo Li Xi’an Commercial Facility – Shaanxi
The Swire Pptys – Taikoo Li Xi’an Commercial Facility – Shaanxi project involves the construction of a commercial facility in Qujiang New District, Xi’an City, Shaanxi Province, China. Equip yourself with the essential tools needed to make informed and profitable decisions with our Swire Pptys – Taikoo Li Xi’an Commercial Facility – Shaanxi report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase,...
-
Thematic Analysis
Batteries – Thematic Intelligence
Explore the following trends and insights from the ‘Batteries’ thematic report: Synopsis of the batteries theme and understand its progress over the past decade. Key trends impacting the growth of the theme over the next 12 to 24 months, namely, technology trends, macroeconomic trends, and regulatory trends. Multiple data sets, including patents and M&A trends, to set smart business goals. The report also provides a timeline highlighting milestones in the development of the batteries. Core segments of the value chain, including...
-
Product Insights
Urine Analysis Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Urine Analysis Pipeline Market Report Overview Urine analysis refers to the analysis of urine to aid in the diagnosis of disease or to detect the presence of a specific substance. The Urine Analysis pipeline market research report provides comprehensive information about the Urine Analysis pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Urine Analyzers ·       Urine Analyzer Reagents Key Territories ·       ...
-
Product Insights
Chifeng Chaihulanzi Mine
The Chifeng Chaihulanzi Mine is a gold mine in China. It is currently in operation. Empower your strategies with our Chifeng Chaihulanzi Mine report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain...